12:00 AM
 | 
May 25, 2009
 |  BC Week In Review  |  Company News  |  Other News

Prospect Therapeutics cancer news

On June 29, Prospect Therapeutics' IP, regulatory dossier, fixed assets and clinical inventory...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >